- Anatomy Of The National Drug Code
- DSCSA: Special Privileges For The "Big-3" Wholesale Distributors, Part 1
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- The Case Against RFID In Pharma
- The Aggregation Hoax and PIA
- DSCSA: Special Privileges For The “Big-3″ Wholesale Distributors, Part 2
- Pharma Supply Chain Companies Organize To Establish Global Traceability Data Exchange Architecture
Archive for the ‘Supply Network Blog’ Category
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
RxTrace offers unique context and focus on our industry.
RxTrace is informative and well-written. It’s my ‘go to’ source for information on serialization and DSCSA.
RxTrace is the most informative and most current source for information on tracking pharma using AIDC. Their integration of information on UDI is also rather unique. RxTrace serves the pharma stakeholders as the pharma business model evolves to include services enabled by AIDC.
The knowledge presented in RxTrace, not simply the more common focus of the manufacturing, packaging, and regulatory requirements, but Dirk’s wholesale experience provides him with a complex view on the impacts to the end-to-end supply chain.
The information provided is up-to-date and provides a pragmatic presentation and discussion of the pertinent issues as they unfold. It is an excellent and comprehensive summary.
Easy to understand summary and discussion of complex current topics.
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
RxTrace is my go-to source for information surrounding the implementation and implications of the Drug Quality and Security Act.
Look forward to RxTrace News-helps me to better manage key issues
GS1 Healthcare US Publishes Updated Guidance For DSCSA wp.me/pN6hS-1vZ
September 19, 2014 (5:42)
Is Your Drug Exempt From The Federal Drug Supply Chain Security Act?You mentioned that, "as long as it is recognized by the FDA as a product that...
Dirk A. Rodgers
September 4, 2014 (1:15)
Is Your Drug Exempt From The Federal Drug Supply Chain Security Act? RevisitedPam, Thanks for the supportive comment. I'm not aware of anyone who writes a...
September 4, 2014 (12:45)
Is Your Drug Exempt From The Federal Drug Supply Chain Security Act? RevisitedGood afternoon Dirk, I truly enjoy reading your essays. I like how it expl...
August 25, 2014 (9:40)
Pharma Supply Chain Companies Organize To Establish Global Traceability Data Exchange ArchitectureDear Dirk, The rumours you heard in the early spring are true and we are s...
August 18, 2014 (9:20)
2014 Fall Conference Season PreviewDirk, thanks for the list. I'll be at the GS1 and HDMA events. Thinking about...